Cantor Fitzgerald Raises Earnings Estimates for Nyxoah
Nyxoah SA (NASDAQ:NYXH - Free Report) - Research analysts at Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Nyxoah in a report released on Wednesday, November 19th. Cantor...
Nyxoah (NASDAQ:NYXH - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.74) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by...
MarketBeat·11d ago
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah (NYXH) delivered earnings and revenue surprises of -21.31% and +18.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +11.94% and +2.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·26d ago
Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·27d ago
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.
Zacks·2mo ago
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder
Nyxoah CEO Olivier Taelman said that the company has also trained surgeons, obtained Value Analysis Committee approvals, and achieved successful coverage from major payors.
Stocktwits·2mo ago
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
Zacks·2mo ago
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.